ASMB

Assembly Biosciences (ASMB)

About Assembly Biosciences (ASMB)

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.

Details

Daily high

$14.75

Daily low

$14.31

Price at open

$14.74

52 Week High

$20.04

52 Week Low

$7.69

Market cap

93.4M

Dividend yield

0.00%

Volume

14,642

Avg. volume

36,896

P/E ratio

-1.65

Assembly Biosciences News